期刊文献+

两种甲状腺功能亢进症动物模型的对比研究 被引量:5

A comparative study of two hyperthyroidism models induced by Yersiniaenterocolitica and Euthyrox
下载PDF
导出
摘要 目的复制两种甲状腺功能亢进症动物模型,对比研究它们成型性及可持续性的异同,为研究治疗甲亢的药物提供良好的评价载体。方法优甲乐模型:大鼠灌胃给予优甲乐50μg/100 g鼠重共21 d,于末次给药后第1、7、14天分别于眼底取血和接取尿液,检测相关指标;小肠结肠炎耶尔森氏菌模型:大鼠尾静脉注射小肠结肠炎耶尔森氏菌,于第0、5、10、15、20天共注射5次,并于末次注射后第5、15、25天大鼠眼底取血和接取尿液,检测相关指标。结果优甲乐模型:造模后T3、T4、FT3、FT4显著升高,但造模型后1周即恢复正常,尿液代谢的PCA图中显示模型组整体代谢网络偏离空白组,2周后恢复正常;小肠结肠炎耶尔森氏菌模型:造模后第15天和25天时T3和T4升高,第25天时TSH显著升高,尿液代谢的PCA图中模型组偏离空白组,而第15天和25天时未回到空白组位置。结论优甲乐甲亢模型成型性好但恢复迅速,作为药效评价时适合预防给药;而小肠结肠炎耶尔森氏菌甲亢模型成型性好并且持续性较好,作为药效评价时可采取治疗给药方式。 Objective To provide a good evaluation for research the hyperthyroidism drugs , two kinds of hyperthyroidism animal models were copied , and compared the similarities and differences of their formability and sustainability.Methods Euthyrox-induced model: The rat was taken Euthyrox (50μg· 100g-1 rat weight) for 21 d. And then the blood and urine were collected in 1 d, 7 d and 14 d after last time oral administration of Euthyrox;Yersiniaenterocolitica-induced model:the rats were injected Yersiniaenterocolitica (YE) in 0、5、10、15、20 (IOCV).And then the blood and urine were collected in 5d, 15d and 25d after last IOCV of YE.Results Euthyrox-induced model:T3, T4, FT3, FT4 were increased significantly , but returned normal 1 week later in the model group , PCA showed that model group deviated from the blank group , but recovered 2 weeks later; Yersiniaenterocolitica-induced model: T3 and T4 were increased significantly in 15 and 25 d, TSH significant raised in 25 d, the model group deviated from the blank group in PCA, and didn’t return to the blank group in 15d or 25d.Conclusion Euthyrox-induced modelhas good formability butrecovered quickly , which is suitable for prevention of drug delivery on efficacy evaluation; Yersiniaenterocolitica-induced model with good formability and sustainability could be used for treatment of drug delivery on efficacy evaluation .
出处 《中国比较医学杂志》 CAS 2014年第7期19-24,I0003,共7页 Chinese Journal of Comparative Medicine
基金 国家自然科学基金(81302898) 黑龙江省研究生创新科研项目(YJSCX2012-356HLJ) 黑龙江省青年科学基金(QC2012C038) 黑龙江中医药大学科研基金(B201104) 黑龙江省教育厅科学技术研究项目(12541744)
关键词 甲状腺功能亢进症 模型 动物 优甲乐 小肠结肠炎耶尔森氏菌 对比研究 Hyperthyroidism Model,animal Euthyrox Yersiniaenterocolitica Comparative study
  • 相关文献

参考文献7

二级参考文献73

  • 1张宏伟,陈如泉,王巧云,文哲双.益气养阴方对甲亢阻虚大鼠的治疗作用[J].辽宁中医杂志,1994,21(5):235-236. 被引量:14
  • 2赵桂云,王海生,赵桂香.FT_3、FT_4 RIA在突眼患者中的临床应用[J].放射免疫学杂志,2007,20(1):53-53. 被引量:6
  • 3Klein I,Ojamaa K.Thyroid hormone:targeting the vascular smooth muscle cell[J].Circ Res,2001 Feb 16,88(3):260-264.
  • 4Fukuyama K,Ichiki T,Takeda K,et al.Downregulation of Vascular Angiotensin II Type 1 Receptor by Thyroid Hormone[J].Hypertension,2003,41:598-603.
  • 5Serafino F,Emiliano A.Palmieri,et al.Effects of Thyroid Hormone on the Cardiovascular System[J].Recent Progress in Hormone Research,2004,59:31-50.
  • 6Marchant C,Brown L,Sernia C.Renin-angiotensin system in thyroid dysfunction in rats[J].Cardiovasc Pharmacol,1993,22:449-455.
  • 7Raffaele N,Bernadette B,Vincenzo G,et al.Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans[J].Circulation,2001,104:3076-3080.
  • 8Kiselev VI,Treshutin VA.Role of the blood kallikrein-kinin system in activating hemodynamic effects induced by L-thyroxine[J].Probl Endokrinol(Mosk),1982,28(1):78-81.
  • 9Hu LW,Benvenuti LA,Liberti EA,et al.Thyroxineinduced cardiac hypertrophy:influence of adrenergic nervous system versus renin-angiotensin system on myocyte remodeling[J].Physiol Regul Integr Comp Physiol,2003,285:R1473-R1480.
  • 10胡方林.中医药内外合治甲亢的思路[J].光明中医,2007,22(8):9-10. 被引量:8

共引文献25

同被引文献81

  • 1高莉囡,王海波,吴丹,淡以锐.化学发光免疫法检测甲状腺激素及抗体结果的临床意义[J].吉林医药学院学报,2013,34(1):10-12. 被引量:9
  • 2张薇,侯连兵,李平,刘旻,阎玺庆,周红玲,曾芬.因宁片对实验性甲亢阴虚大鼠的药效学研究[J].中药材,2007,30(3):326-328. 被引量:3
  • 3周凌燕,陈泽奇,李炜,李智,颜永平.甲状腺功能亢进肝阳上亢证大鼠下丘脑组织蛋白质差异表达的观察[J].中国中医药信息杂志,2007,14(5):18-20. 被引量:7
  • 4Somwaru LL,ArnoldAM,Joshi N,et aI.High frequency of andfactors associated with thyroidhormoneover- replacement andunder-replacement in men and women aged65 andover.JClin Endocrinol Metab. 2009;94(4): 1342-1345.
  • 5Turner MR, Camacho X, Fischer HD, et al. Levothyroxine dose and risk of fractures in older adults nested case-control study. BMJ.2011;342: d2238.
  • 6Mazziotti G, Porcelli T, Patelli I, et al. Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. Bone.2010;46(3): 747-751.
  • 7FlynnRW, BonellieSR,JungRT, etal.Serumthyroid-stimul ating hormone concentration and morbidity from cardiovascular disease and fractures in patierlts on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010; 95(1): 186-193.
  • 8Ko Y J, Kim JY, Lee J, et al. Levothyroxine dose and fracture risk according to the osteoporosis status in elderly women.J Prev Med Public Health.2014;47(1): 36-46.
  • 9Wang Z,Zhang Q,Lu J,et al. Identification of outer membrane porin f protein of Yersinia enterocolitica recognized by antithyrotopin receptor antibodies in Graves ' disease and determination of its epitope using mass spectrometry and bioinformatics tools. JClin Endocrinol MeTab. 2010;95(8):4012-4020.
  • 10Hargreaves CE,Grasso M,Hampe CS,et al. Yersinia enterocolitica provides the link between thyroid-stimulating antibodies and their germline counterparts in Graves'disease. J Immunol. 2013; 190(11):5373 -5381.

引证文献5

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部